MannKind Corp (MNKD)
Healthcare
Biotechnology
3.80 $
-2.8%
vs. previous close
Closing price · As of: 3. Aug 2026
MannKind Corp (MNKD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -5.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.6 | 8.7 | 22 | 6.7 | 3.8 | 9.3 | 23 | -6.4 | 9.0 | 23 | -8.0 | -5.6 | 19 | |
| 1.5 | 1.4 | 1.5 | 1.7 | 2.1 | 2.6 | 2.7 | 2.7 | 2.6 | 2.8 | 4.2 | 6.4 | 16 | |
| 5.6 | 4.6 | 3.8 | 3.9 | 6.4 | 5.2 | 5.8 | 5.4 | 7.5 | 4.3 | 7.0 | 6.5 | 25 | |
| 8.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.2 | 9.1 | 3.4 | -14 | -10 | -5.0 | -4.2 | -30 | -12 | -0.8 | -72 | -5.0 | -89 | |
| 17 | 11 | 5.9 | 2.4 | 3.0 | 1.4 | 2.9 | 0.3 | 1.1 | 1.1 | 2.0 | 1.9 | 6.1 | |
| 3.7 | -12 | -7.9 | -48 | -55 | -41 | 48 | 6.0 | 6.3 | -25 | -292 | 19 | -292 | |
| 8.5 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -8.5 | -1.7 | 0.0 | – | -4.7 | -1.5 | – | – | – | – | – | – | – | |
| 0.0 | – | – | – | – | 0.0 | -88 | 0.0 | 0.0 | 75 | 250 | -36 | 289 | |
| -5.9 | -0.3 | 142 | -3.5 | -45 | -2.3 | -87 | 1.4 | -5.5 | 72 | 247 | -35 | 279 | |
| 0.3 | -3.2 | 155 | -45 | -96 | -34 | -16 | 1.0 | 9.7 | 70 | -53 | -22 | 5.5 | |
| -14 | -2.7 | 16 | 4.3 | 0.9 | 7.9 | 20 | -6.7 | 7.8 | 22 | -10.0 | -7.5 | 13 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.